Automated detection of inaccurate and imprecise transitions in peptide quantification by multiple reaction monitoring mass spectrometry.

BACKGROUND Multiple reaction monitoring mass spectrometry (MRM-MS) of peptides with stable isotope-labeled internal standards (SISs) is increasingly being used to develop quantitative assays for proteins in complex biological matrices. These assays can be highly precise and quantitative, but the frequent occurrence of interferences requires that MRM-MS data be manually reviewed, a time-intensive process subject to human error. We developed an algorithm that identifies inaccurate transition data based on the presence of interfering signal or inconsistent recovery among replicate samples. METHODS The algorithm objectively evaluates MRM-MS data with 2 orthogonal approaches. First, it compares the relative product ion intensities of the analyte peptide to those of the SIS peptide and uses a t-test to determine if they are significantly different. A CV is then calculated from the ratio of the analyte peak area to the SIS peak area from the sample replicates. RESULTS The algorithm identified problematic transitions and achieved accuracies of 94%-100%, with a sensitivity and specificity of 83%-100% for correct identification of errant transitions. The algorithm was robust when challenged with multiple types of interferences and problematic transitions. CONCLUSIONS This algorithm for automated detection of inaccurate and imprecise transitions (AuDIT) in MRM-MS data reduces the time required for manual and subjective inspection of data, improves the overall accuracy of data analysis, and is easily implemented into the standard data-analysis work flow. AuDIT currently works with results exported from MRM-MS data-processing software packages and may be implemented as an analysis tool within such software.

[1]  Bernhard Spengler,et al.  De novo sequencing, peptide composition analysis, and composition-based sequencing: A new strategy employing accurate mass determination by fourier transform ion cyclotron resonance mass spectrometry , 2004, Journal of the American Society for Mass Spectrometry.

[2]  Peter R. Baker,et al.  Role of accurate mass measurement (+/- 10 ppm) in protein identification strategies employing MS or MS/MS and database searching. , 1999, Analytical chemistry.

[3]  Thomas Lengauer,et al.  ROCR: visualizing classifier performance in R , 2005, Bioinform..

[4]  D R Mani,et al.  Developing multiplexed assays for troponin I and interleukin-33 in plasma by peptide immunoaffinity enrichment and targeted mass spectrometry. , 2009, Clinical chemistry.

[5]  J. Vargo Determination of sulfonic acid degradates of chloroacetanilide and chloroacetamide herbicides in groundwater by LC/MS/MS. , 1998, Analytical chemistry.

[6]  Xu Shi,et al.  Quantification of Cardiovascular Biomarkers in Patient Plasma by Targeted Mass Spectrometry and Stable Isotope Dilution* , 2009, Molecular & Cellular Proteomics.

[7]  B. Matuszewski,et al.  Matrix effect in quantitative LC/MS/MS analyses of biological fluids: a method for determination of finasteride in human plasma at picogram per milliliter concentrations. , 1998, Analytical chemistry.

[8]  J A Sphon,et al.  Use of mass spectrometry for confirmation of animal drug residues. , 1978, Journal - Association of Official Analytical Chemists.

[9]  L L Needham,et al.  Isotope dilution--mass spectrometric quantification of specific proteins: model application with apolipoprotein A-I. , 1996, Clinical chemistry.

[10]  Jeffrey R. Whiteaker,et al.  Antibody-based enrichment of peptides on magnetic beads for mass-spectrometry-based quantification of serum biomarkers. , 2007, Analytical biochemistry.

[11]  J. Mandel,et al.  Total serum cholesterol by isotope dilution/mass spectrometry: a candidate definitive method. , 1980, Clinical chemistry.

[12]  Zhengyin Yan,et al.  Isobaric metabolite interferences and the requirement for close examination of raw data in addition to stringent chromatographic separations in liquid chromatography/tandem mass spectrometric analysis of drugs in biological matrix. , 2008, Rapid communications in mass spectrometry : RCM.

[13]  Timothy Olah,et al.  Mechanistic investigation of ionization suppression in electrospray ionization , 2000, Journal of the American Society for Mass Spectrometry.

[14]  L. Romanyshyn,et al.  Implications of matrix effects in ultra-fast gradient or fast isocratic liquid chromatography with mass spectrometry in drug discovery. , 2002, Rapid communications in mass spectrometry : RCM.

[15]  H. Parsons Stable isotopes in the management and diagnosis of inborn errors of metabolism. , 1990, Canadian journal of physiology and pharmacology.

[16]  S. Stein,et al.  Establishing the fitness for purpose of mass spectrometric methods , 2003, Journal of the American Society for Mass Spectrometry.

[17]  Tom Fawcett,et al.  ROC Graphs: Notes and Practical Considerations for Researchers , 2007 .

[18]  L. Lucentini,et al.  Quantitation of anabolic hormones and their metabolites in bovine serum and urine by liquid chromatography-tandem mass spectrometry. , 2000, Journal of chromatography. A.

[19]  Gennifer E. Merrihew,et al.  Expediting the development of targeted SRM assays: using data from shotgun proteomics to automate method development. , 2009, Journal of proteome research.

[20]  S. Hanks,et al.  Absolute quantification of phosphorylation on the kinase activation loop of cellular focal adhesion kinase by stable isotope dilution liquid chromatography/mass spectrometry. , 2009, Analytical chemistry.

[21]  S. Stein,et al.  On the risk of false positive identification using multiple ion monitoring in qualitative mass spectrometry: Large-scale intercomparisons with a comprehensive mass spectral library , 2006, Journal of the American Society for Mass Spectrometry.

[22]  Lukas N. Mueller,et al.  Full Dynamic Range Proteome Analysis of S. cerevisiae by Targeted Proteomics , 2009, Cell.

[23]  Susan E Abbatiello,et al.  Mass spectrometric quantification of asparagine synthetase in circulating leukemia cells from acute lymphoblastic leukemia patients. , 2008, Journal of proteomics.

[24]  S. Carr,et al.  Quantitative, Multiplexed Assays for Low Abundance Proteins in Plasma by Targeted Mass Spectrometry and Stable Isotope Dilution*S , 2007, Molecular & Cellular Proteomics.

[25]  Morton B. Brown 400: A Method for Combining Non-Independent, One-Sided Tests of Significance , 1975 .

[26]  J. Kost,et al.  Combining dependent P-values , 2002 .

[27]  T. Kuhara Noninvasive human metabolome analysis for differential diagnosis of inborn errors of metabolism. , 2007, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[28]  Steven A Carr,et al.  Protein biomarker discovery and validation: the long and uncertain path to clinical utility , 2006, Nature Biotechnology.

[29]  P. Kebarle,et al.  Dependence of ion intensity in electrospray mass spectrometry on the concentration of the analytes in the electrosprayed solution , 1993 .

[30]  Christoph H Borchers,et al.  Multi-site assessment of the precision and reproducibility of multiple reaction monitoring–based measurements of proteins in plasma , 2009, Nature Biotechnology.

[31]  K. Cios,et al.  Improved Validation of Peptide MS/MS Assignments Using Spectral Intensity Prediction*S , 2007, Molecular & Cellular Proteomics.

[32]  C. Sweeley,et al.  On-line computer controlled multiple ion detection in combined gas chromatography-mass spectrometry. , 1973, Analytical chemistry.

[33]  T. Browne Stable Isotopes in Pharmacology Studies: Present and Future , 1986, Journal of clinical pharmacology.

[34]  R. Yost,et al.  Triple quadrupole mass spectrometry for direct mixture analysis and structure elucidation. , 1979, Analytical chemistry.

[35]  J. Pitt,et al.  Comprehensive screening of urine samples for inborn errors of metabolism by electrospray tandem mass spectrometry. , 2002, Clinical chemistry.

[36]  M. McKay,et al.  Unique Ion Signature Mass Spectrometry, a Deterministic Method to Assign Peptide Identity , 2009, Molecular & Cellular Proteomics.

[37]  Jacob D. Jaffe,et al.  Accurate Inclusion Mass Screening , 2008, Molecular & Cellular Proteomics.

[38]  B. Davis,et al.  LC-MS/MS Quantification of Zn-α2 Glycoprotein: A Potential Serum Biomarker for Prostate Cancer , 2007 .

[39]  R. Aebersold,et al.  Selected reaction monitoring for quantitative proteomics: a tutorial , 2008, Molecular systems biology.

[40]  W. C. Brumley,et al.  Regulatory mass spectrometry. , 1981, Biomedical mass spectrometry.

[41]  Tom Fawcett,et al.  An introduction to ROC analysis , 2006, Pattern Recognit. Lett..

[42]  Damon May,et al.  MRMer, an Interactive Open Source and Cross-platform System for Data Extraction and Visualization of Multiple Reaction Monitoring Experiments*S⃞ , 2008, Molecular & Cellular Proteomics.

[43]  S. Gygi,et al.  Absolute quantification of proteins and phosphoproteins from cell lysates by tandem MS , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[44]  A. Rockwood,et al.  Assessing analytical specificity in quantitative analysis using tandem mass spectrometry. , 2005, Clinical biochemistry.

[45]  Y. Benjamini,et al.  Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .

[46]  L. J. Moore,et al.  High accuracy determination of calcium in blood serum by isotope dilution mass spectrometry. , 1972, Analytical chemistry.